DAA131 |
mitogen-activated protein kinase 1 |
Molecular |
brain |
Human |
MAPK1 |
17.0% Decrease Gene Expression Level |
|
DAA132 |
mitogen-activated protein kinase 9 |
Molecular |
brain |
Human |
MAPK9 |
15.0% Decrease Gene Expression Level |
|
DAA130 |
mitogen-activated protein kinase kinase 1 |
Molecular |
brain |
Human |
MAP2K1 |
7.0% Decrease Gene Expression Level |
|
DAA140 |
monocyte to macrophage differentiation-associated |
Molecular |
brain |
Human |
MMD |
7.0% Decrease Gene Expression Level |
|
DAA1943 |
Motor coordination decreases |
Physiological |
musculoskeletal system, nervous system |
Mouse |
— |
— |
|
DAA742 |
Motor function impairment evident in altered gait and balance |
Physiological |
nervous system |
Human |
— |
— |
|
DAA1224 |
MTHFR methylation decrease |
Molecular |
prefrontal cortex |
Human |
— |
— |
|
DAA70 |
multiple EGF-like-domains 8 |
Molecular |
brain |
Human |
MEGF8 |
27.0% Decrease Gene Expression Level |
|
DAA134 |
muscleblind-like 2 (Drosophila) |
Molecular |
brain |
Human |
MBNL2 |
12.0% Decrease Gene Expression Level |
|
DAA2026 |
Mutations in mitochondrial DNA accumulate |
Physiological |
heart, kidney, skeletal muscle, cerebral cortex, cerebellum |
Human |
— |
— |
|
DAA2026 |
Mutations in mitochondrial DNA accumulate |
Physiological |
heart, kidney, skeletal muscle, cerebral cortex, cerebellum |
Human |
— |
— |
|
DAA2216 |
myeloid differentiation primary response gene (88) increases with age |
Molecular |
hippocampus |
Human |
MYD88 |
59.3% Increase Gene Expression Level |
|
DAA2242 |
myeloid differentiation primary response gene (88) increases with age |
Molecular |
frontal lobe |
Human |
MYD88 |
58.7% Increase Gene Expression Level |
|
DAA2230 |
myeloid differentiation primary response gene (88) increases with age |
Molecular |
parietal lobe |
Human |
MYD88 |
54.8% Increase Gene Expression Level |
|
DAA1102 |
Myogenic Differentiation 1 |
Molecular |
frontal lobe |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA1104 |
Myogenic Differentiation 1 |
Molecular |
temporal lobe |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA1101 |
Myogenic Differentiation 1 |
Molecular |
cerebellum |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA1103 |
Myogenic Differentiation 1 |
Molecular |
pons |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA145 |
myosin VI |
Molecular |
brain |
Human |
MYO6 |
18.0% Increase Gene Expression Level |
|
DAA144 |
myosin X |
Molecular |
brain |
Human |
MYO10 |
20.0% Increase Gene Expression Level |
|
DAA1389 |
N-acetyltransferase 15 (GCN5-related, putative) |
Molecular |
hippocampus |
Mouse |
Nat15 |
1.0% Decrease Gene Expression Level |
|
DAA154 |
N-ethylmaleimide-sensitive factor |
Molecular |
brain |
Human |
NSF |
10.0% Decrease Gene Expression Level |
|
DAA146 |
N-ethylmaleimide-sensitive factor attachment protein, alpha |
Molecular |
brain |
Human |
NAPA |
13.0% Decrease Gene Expression Level |
|
DAA147 |
N-ethylmaleimide-sensitive factor attachment protein, gamma |
Molecular |
brain |
Human |
NAPG |
23.0% Decrease Gene Expression Level |
|
DAA2036 |
Neural stem cell pool declines |
Physiological |
hippocampus |
Mouse |
— |
— |
|